Showing results (91-100 of 315) with videos related to
Sort By:
Pageof 32
Gut|July 1, 1980
Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitisD S Rampton, G E Sladen, L J YoultenAlimentary Pharmacology & Therapeutics|June 10, 2000
Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel diseaseE Carty, M Macey, S A McCartney, et al.Clinical Allergy|May 1, 1982
The effect of disodium cromoglycate on rectal mucosal histamine release, eosinophil exudation and disease activity in active ulcerative colitisD S Rampton, M J Brown, R Causon, et al.Gut|October 1, 1983
Imbalance of prostacyclin and thromboxane synthesis in Crohn's diseaseC J Hawkey, F Karmeli, D RachmilewitzGut|March 13, 2003
Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitorsC J Hawkey, M J S LangmanGut|August 1, 1994
Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugsN Hudson, S Everitt, C J HawkeyJournal of Clinical Pathology|May 3, 2002
Thromboxane synthase immunohistochemistry in inflammatory bowel diseaseE Carty, C Nickols, R M Feakins, et al.Gut|March 15, 2001
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugsS G Nugent, D Kumar, D S Rampton, et al.International Journal of Colorectal Disease|January 1, 1996
Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological cluesC S Probert, V Jayanthi, D S Rampton, et al.European Journal of Gastroenterology & Hepatology|February 21, 1998
Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel diseaseC E Collins, D S Rampton, J Rogers, et al.Pageof 32